The three title compounds form part of a set of important precursor dissacharides which lead to novel therapeutics, in particular for Alzheimer's disease. All three crystallize as poorly diffracting crystals with one independent molecule in the asymmetric unit. 
The three title compounds form part of a set of important precursor dissacharides which lead to novel therapeutics, in particular for Alzheimer's disease. All three crystallize as poorly diffracting crystals with one independent molecule in the asymmetric unit. Two of them are isostructural: 4-methoxyphenyl 4-O-[6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-4-O-(9-fluorenylmethyloxycarbonyl)--d-glucopyranosyl]-2-O-benzoyl-3-O-benzyl-6-O-chloroacetyl--l-idopyranoside, C 59 H 56 ClN 3 O 16 , (I), the ido-relative of a reported gluco-disaccharide [Gainsford et al., 2013) . Acta Cryst. (III) , illustrates that a slightly larger set of weak intermolecular interactions can result in a less disordered molecular arrangement. The molecules are bound by weak C-HÁ Á ÁO(ether) hydrogen bonds in (I) and (II), augmented by C-HÁ Á Á interactions in (III). The absolute configurations were determined, although at varying levels of significance from the limited observed data.
Chemical context
Heparan sulfate (HS) is a linear polysaccharide with a disaccharide repeating unit of d-glucosamine and l-iduronic or d-glucuronic acid, which can be O-or N-sulfated or N-acetylated. HS is involved in the regulation of many important biological processes (Bishop et al., 2007; Turnbull et al., 2001) . Synthetic HS-oligosaccharides with high potency as -secretase (BACE1) inhibitors might have an application as novel therapeutics for Alzheimer's disease Scholefield et al., 2003) .
In our recent paper (Schwö rer et al., 2013), we described the synthesis and inhibition data of a library of such oligosaccharides. At the centre of the synthetic methodology are highly orthogonally protected disaccharide building blocks, three of them being the subjects of this paper. The disaccharides can be converted into glycosyl donors by hydrolysis of the methoxyphenyl glycoside and formation of the corresponding trichloroacemidate; while the azide and the orthogonal ester protecting groups provide selective access to further functionalization later in the synthesis.
While pursuing precursor disaccharides with possible application in the treatment of Alzheimer's disease, we have prepared some ido-and gluco-related crystals of the published gluco-derivative 4-methoxyphenyl 4-O-[6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-4-O-(9-fluorenylmethyloxycarbonyl)--dglucopyranosyl]-2-O-benzoyl-3-O-benzyl-6-O-chloroacetyl--d-glucopyranoside, hereafter RSTE (Gainsford et al., 2013) . We have been intrigued that no unambiguous defining set of intermolecular attractive interactions has been observed (Gainsford et al., 2012) for these four structures and three other in-house examples.
Structural commentary

4-Methoxyphenyl 4-O-[6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-4-O-(9-fluorenylmethyloxycarbonyl)-a-D-glucopyranosyl]-2-O-benzoyl-3-O-benzyl-6-O-chloroacetyl-a-L-idopyranoside, (I) (hereafter OZTF)
The asymmetric unit contains one independent molecule of the title compound ( Fig. 1 ) with the pyranose rings in chair conformations ( Table 1 ). The determined absolute configuration confirmed the expected stereochemistry: C1(S),
C2(R), C3(S), C4(S), C5(S), C30(S), C31(R), C32(S), C33(R), C34(R), C47(R).
Conformational two-site disorder models were required for the pendant 6-O-chloroacetyl and methyl of the 6-O-acetyl groups.
(
I4-Methoxyphenyl 4-O-[6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-4-O-(9-fluorenylmethyloxycarbonyl)-a-D-glucopyranosyl]-2-O-benzoyl-3-O-benzyl-6-O-methoxyoacetyl-a-L-idopyranoside, (II) (hereafter RNSB)
This molecule ( Fig. 2) crystallized in an isostructural cell to (I), as shown in Fig. 3 . A comparison of the molecules of (I) Table 1 Conformational parameters (Å , ) (Cremer & Pople, 1975) for iodo-pyranose rings.
Head_D and Foot_D represent the distance from the four-atom 'seat' plane. Notes: (a) AQOGIW (Lee et al., 2004) . Table 2 Conformational parameters (Å , ) (Cremer & Pople, 1975) Notes: (a) RSTE molecules 1 and 2 (Gainsford et al., 2013) ; (b) RAVNAD (Abboud et al., 1997) .
Figure 4
An ORTEP-3 (Farrugia, 2012) view of (III) showing the asymmetric unit and labels with 30% probability ellipsoids. H atoms have been omitted for clarity. Only one (A) of the disordered conformations for atoms C13-C19 and O6, and C29, C52 and O52 (see text) are shown.
the b axis in which R 2 2 (18) and C(n) (n = 5,17) motifs (Bernstein et al., 1995) are present.
Database survey
There are only a few reported 2-azido pyranose-based disaccharide structures in the Cambridge Structural Database (Version 5.36, with February 2015 update; Groom & Allen, 2014) : our published glucopyranoside (Gainsford et al., 2013; BILJAJ) , a mannopyranoside (Luger & Paulsen, 1981; BABHUH) and one idopyranose (Lee et al., 2004; AQOGIW) . We note another disaccharide glucopyranose (Abboud et al., 1997; RAVNAD) for comparison. The conformational data given in Tables 1 and 2 show the pyranose essential chair conformations have not been disturbed significantly, although the ring with the bound azide seems to be closer to a 'pure' chair conformation by the criteria (Cremer & Pople, 1975) .
Synthesis and crystallization
The title compounds were prepared as described in Schwö rer et al. (2013) . Crystals were obtained by vapour diffusion of petroleum ether into a solution of the title compounds in ethyl acetate (I) or toluene (II) and (III).
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 6 . Subject to variations noted below, the methyl H atoms were constrained to an ideal geometry (C-H = 0.98 Å ) with U iso (H) = 1.5U eq (C), but were allowed to rotate freely about the adjacent C-C bonds. All other H atoms were placed in geometrically idealized positions and constrained to ride on their parent atoms with C-H distances of 0.95 (aromatic), 0.99 (methylene) or 1.00 (tertiary) Å with U iso (H) = 1.2U eq (C) or 1.5U eq (C) (for methyl C) of their parent atom. Specific variations were:
(I) Data at resolution less than 1.12 Å was not significantly above the noise level and was excluded from the refinement. One other reflection (1,0,9) was OMITted as an outlier. Data analysis shows that there are many data in the resolution range 1.40-1.12 Å that are in poor agreement reflecting crystal quality.
There was conformational disorder in the chloroacetoxy (atoms C28, C29, O9 and Cl1) and the methoxycarbonyloxy (atoms C37, C37 and O12) groups which was modelled as two (A and B) groups. Because of proximity, and poor data quality, these atoms were unable to be refined with anisotropic Table 3 Hydrogen-bond geometry (Å , ) for OZTF.
Cg9 is the centroid of the C54-C59 ring. Symmetry codes: (i) x; y À 1; z; (ii) Àx þ 1; y þ 1 2 ; Àz þ 1; (iii) x þ 1; y; z; (iv) Àx þ 2; y À 1 2 ; Àz.
Table 4
Hydrogen-bond geometry (Å , ) for RNSB. 
Table 5
Hydrogen-bond geometry (Å , ) for RSTN.
Cg3, Cg5 and Cg6 are the centroids of the C6-C11, C21-C26 and C39-C44 phenyl rings, respectively. 
Figure 5
Cell-packing view (Macrae et al., 2008) of (I) showing representative hydrogen-bonding interactions (see Table 3 ). The C-HÁ Á Á interaction is shown by atoms H16 and C59. [Symmetry codes: (i) x, y À 1, z; (ii) Àx + 1, y À thermal parameters. It proved advisable to add additional restraints to retain known geometries based on published structures for these groups. So (SHELXL DFIX) C28-C29 pairs were held to 1.50 (3) Å ; C28-O9 to 1.20 Å and samedistance constraints (SADI, 0.02) were applied to C29-Cl1, C36-C37 and C36-O11. Thermal parameters were also linked using SIMU for ring atoms C6-C11 and atom pairs C53 and C54, O12A and O12B, C37A and C37B, and C36A and C36B. Finally, rings C6-C11 and C14-C19 were constrained to hexagonal geometry with C-C = 1.390 Å . Final A:B occupancies for the chloroacetoxy group were 0.509 (17):0.491 (17) and for the methoxycarbonyloxy, 0.44 (4):0.56 (4).
(II) Data at resolution less than 0.81 Å was not significantly above the noise level and was excluded from the refinement. Two reflections (17,1,7; 6,9,5) were OMITted as clear outlier data. There was two-site conformational disorder for the methoxylacetyl atoms C36 and O12 (labelled A and B, respectively). Atoms C13, C33, C34, C30, C361 and C36B were restrained to isotropic-like behaviour (using ISOR) and the two-model disordered atoms (O12A, O12B; C36A, C36B) were given the same anisotropic thermal parameters. Distance constraints (SADI, 0.3) were applied to the C36A-O12A and C36B-O12B bonds. Final A:B occupancies for the methoxyacetyl atoms were 0.797 (16):0.203 (16) .
(III) One reflection was removed as an outlier as well as nine low angle reflections affected by the beamstop (F o <<F c ). The molecule showed two major orientations for the benzyl group (atoms C13-C19) refined by two refining set occupancies [A:B 0.793 (6):0.207 (6)] coupled with equivalent U values (SIMU for each ring set) and with each ring restrained to a regular hexagon (C-C 1.39 Å ). In a similar manner, two orientations of atoms C29, O52 and C52 were refined as two conformations: final A:B ratio 0.687 (8):0.313 (8). RNSB; SAINT and SADABS (Bruker, 2005) for RSTN. Program(s) used to solve structure: SHELX-D (Sheldrick, 2008) for OZTF; SHELXS97 (Sheldrick, 2008) for RNSB, RSTN. For all compounds, program(s) used to refine structure:
SHELXL2012 (Sheldrick, 2015) . Molecular graphics: ORTEP-3 in WinGX (Farrugia, 2012) for OZTF; ORTEP-3 in
WinGX (Farrugia, 2012) and Mercury (Macrae et al., 2008) for RNSB; ORTEP-3 (Farrugia, 2012) and Mercury (Macrae et al., 2008) for RSTN. For all compounds, software used to prepare material for publication: SHELXL2012 (Sheldrick, 2015) and PLATON (Spek, 2009) . 
sup-12
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178 (2) C48-C47-C59-C58 −180 (2) C28A-O8-C27-C5 92 (4) C28B-O8-C28A-O9A −52 (5) 
sup-13
4) C35-C31-C32-O14 70 (3) C27-O8-C28B-C29B −174 (4) O10-C31-C32-C33 −57 (3) O9B-C28B-C29B-Cl1B 159 (4) C35-C31-C32-C33 −175 (2) O8-C28B-C29B-Cl1B −17 (6) C38-O13-C33-C34 −123 (2) C36A-O11-C36B-O12B 139 (15) C38-O13-C33-C32 120 (2) C35-O11-C36B-O12B 19 (7) O14-C32-C33-O13 −75 (2) C36A-O11-C36B-C37B −60 (11) C31-C32-C33-O13 173 (2) C35-O11-C36B-C37B −179 (4) O14-C32-C33-C34 169 (2)
Hydrogen-bond geometry (Å, º)
Cg9 is the centroid of the C54-C59 ring. Symmetry codes: (i) x, y−1, z; (ii) −x+1, y+1/2, −z+1; (iii) x+1, y, z; (iv) −x+2, y−1/2, −z.
D-H···A
(RNSB) 4-Methoxyphenyl 4-O-[6-O-acetyl-2-azido-3-O-benzyl-2-deoxy-4-O-(9-fluorenylmethyloxycarbonyl)-α-
D-glucopyranosyl]-2-O-benzoyl-3-O-benzyl-6-O-methoxyacetal-α-L-iodopyranoside
Crystal data 110.6 (6) H60B-C60-H60C 109.5
155.5 (6) O14-C32-C33-C34 168.8 (6) O5-C1-C2-O2 79.3 (7) C31-C32-C33-C34 52.7 (9) O1-C1-C2-O2 −158.3 (6) N2-N1-C34-C33 −71.6 (10) O5-C1-C2-C3 −42.1 (9) N2-N1-C34-C30 165.8 (7) O1-C1-C2-C3 80.3 (7) O13-C33-C34-N1 68.2 (9) C20-O3-C3-C2 −124.4 (7) C32-C33-C34-N1 −172.8 (6) C20-O3-C3-C4 112.5 (7) O13-C33-C34-C30 −172.6 (7)
sup-25
1.0 (14) C49-C48-C53-C52 2.1 (13) C23-C24-C25-C26 0.9 (14) C47-C48-C53-C52 179.7 (7) C24-C25-C26-C21 −1.8 (15) C49-C48-C53-C54 −177.9 (8) C22-C21-C26-C25 0.8 (13) C47-C48-C53-C54 −0.3 (10) C20-C21-C26-C25 −179.6 (8) C52-C53-C54-C55 −0.1 (15) C28-O8-C27-C5 127.8 (9) C48-C53-C54-C55 179.9 (9) O5-C5-C27-O8 −58.5 (9) C52-C53-C54-C59 −179.5 (9) C4-C5-C27-O8 −176.8 (7) C48-C53-C54-C59 0.5 (9) C27-O8-C28-O9 8.6 (16) C59-C54-C55-C56 0.3 (13) C27-O8-C28-C29 −174.8 (9) C53-C54-C55-C56 −179.1 (9) C60-O17-C29-C28 −170.1 (10) C54-C55-C56-C57 −0.1 (15) O9-C28-C29-O17 −179.5 (11) C55-C56-C57-C58 −0.5 (16) O8-C28-C29-O17 3.7 (14) C56-C57-C58-C59
117.8 (8) C46-C47-C59-C58 −58.9 (13) C45-O14-C32-C31 −123.1 (7) C48-C47-C59-C58 −179.9 (9) O10-C31-C32-O14 −172.4 (6) C46-C47-C59-C54 121.4 (9) C35-C31-C32-O14 66.5 (9) C48-C47-C59-C54 0.4 (9) O10-C31-C32-C33 −55.5 (8) 1.0000 C16B-H16B 0.9500 C31-C35
1.500 (4) C17B-C18B 1.3900 C31-C32
1.521 (4) C17B-H17B 0.9500 C31-H31
1.0000 C18B-C19B 1.3900 C32-C33
1.526 (4) C18B-H18B 0.9500 C32-H32
1.0000 C19B-H19B 0.9500
